SCHEMBL9583142

SCHEMBL9583142

CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OCn1cnc2c(N)nc(N)nc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK1 P06493 1/20 0.46
▸ CCNB1 P14635 1/20 0.46
▸ CCNE1 P24864 1/20 0.46
▸ CDK2 P24941 1/20 0.46
▸ PDE3A Q14432 1/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ LMNA P02545 2/20 0.42
▸ MEN1 O00255 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ NFKB1 P19838 1/20 0.40
▸ BLM P54132 1/20 0.40
▸ VCP P55072 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ HIF1A Q16665 1/20 0.40
▸ PRKCA P17252 3/20 0.40
▸ PRKCE Q02156 1/20 0.40
▸ PRKCQ Q04759 1/20 0.40
▸ PRKCD Q05655 1/20 0.40
▸ EP300 Q09472 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9583458 1.00 CDK1 (0.46) CDK1CCNB1CCNE1CDK2PDE3A
SCHEMBL9583245 1.00 CDK1 (0.46) CDK1CCNB1CCNE1CDK2PDE3A
SCHEMBL9583536 1.00 CDK1 (0.46) CDK1CCNB1CCNE1CDK2PDE3A
SCHEMBL9583697 0.91 HDAC6 (0.42) PDE3AALDH1A1LMNAMEN1CYP3A4
SCHEMBL9584540 0.90 HDAC1 (0.42) CDK1PDE3AALDH1A1LMNAMEN1
SCHEMBL9583019 0.90 HDAC1 (0.42) CDK1PDE3AALDH1A1LMNAMEN1
SCHEMBL9584400 0.90 PDE3A (0.41) PDE3AALDH1A1LMNAMEN1CYP3A4
SCHEMBL9583048 0.89 PDE3A (0.40) CDK1CCNB1CCNE1CDK2PDE3A
SCHEMBL9583144 0.89 PDE3A (0.40) CDK1CCNB1CCNE1CDK2PDE3A
SCHEMBL9583957 0.89 ABCB1 (0.41) PDE3AALDH1A1LMNAMEN1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5250535-A Herpes virus; nontoxic; side effect reduction; humans and veterinary medicine SYNTEX INC. (US) 1993-10-05 — — US disclosed
US-4803271-A Process for preparing guanine derivatives SYNTEX (U.S.A.) INC. (US) 1989-02-07 — — US disclosed
US-4612314-A Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent SYNTEX (U.S.A.) INC. (US) 1986-09-16 — — US disclosed
EP-0085424-A2 Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl)purines as antiviral agent SYNTEX (U.S.A.) INC. (US) 1983-08-10 — — EP disclosed
Send feedback